These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24704199)

  • 1. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
    Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
    Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity.
    Kwon YH; Shin TH; Jang MH; Yoon HY; Kang MH; Kang MJ; Choi YW
    J Nanosci Nanotechnol; 2017 Feb; 17(2):1008-17. PubMed ID: 29671978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
    Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
    Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.
    Kang MH; Yoo HJ; Kwon YH; Yoon HY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Mol Pharm; 2015 Dec; 12(12):4200-13. PubMed ID: 26544061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation.
    Kang MJ; Kim BG; Eum JY; Park SH; Choi SE; An JJ; Jang SH; Eum WS; Lee J; Lee MW; Kang K; Oh CH; Choi SY; Choi YW
    J Drug Target; 2011 Aug; 19(7):497-505. PubMed ID: 20738150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution.
    Kim CH; Sung SW; Lee ES; Kang TH; Yoon HY; Goo YT; Cho HR; Kim DY; Kang MJ; Choi YS; Lee S; Choi YW
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30360549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery using polyhistidine peptide-modified liposomes that target endogenous lysosome.
    Hayashi T; Shinagawa M; Kawano T; Iwasaki T
    Biochem Biophys Res Commun; 2018 Jun; 501(3):648-653. PubMed ID: 29746864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
    Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
    Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
    Fu H; Hu GL; He Q
    Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting.
    Xue B; Kozlovskaya V; Sherwani MA; Ratnayaka S; Habib S; Anderson T; Manuvakhova M; Klampfer L; Yusuf N; Kharlampieva E
    Biomacromolecules; 2018 Oct; 19(10):4084-4097. PubMed ID: 30169033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
    Hua S; Vaughan B
    Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Coiled Coil Peptides in Liposomal Anticancer Drug Delivery Using a Zebrafish Xenograft Model.
    Yang J; Shimada Y; Olsthoorn RC; Snaar-Jagalska BE; Spaink HP; Kros A
    ACS Nano; 2016 Aug; 10(8):7428-35. PubMed ID: 27504667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
    J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
    Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.
    Cryan SA; Devocelle M; Moran PJ; Hickey AJ; Kelly JG
    Mol Pharm; 2006; 3(2):104-12. PubMed ID: 16579639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization.
    Suzuki S; Itakura S; Matsui R; Nakayama K; Nishi T; Nishimoto A; Hama S; Kogure K
    Biomacromolecules; 2017 Feb; 18(2):535-543. PubMed ID: 28055201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.